Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
Ovid Therapeutics appointed Dr. Anna Greka, a renowned physician-scientist and biotech entrepreneur, to its Board of Directors, effective June 15, 2026. Dr. Greka brings extensive experience in ion channel biology and CNS drug development, having founded companies whose assets were acquired by Bristol Myers Squibb and AstraZeneca.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.